ArticleClinical case reports2025
Familial Patterns in Acute Lymphoblastic Leukemia: Lessons From Three Siblings.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Familial Patterns in Acute Lymphoblastic Leukemia: Lessons From Three Siblings.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute lymphoblastic leukemia is a sporadic condition and has been reported to be familial in less than 5% of cases. Here, we present the clinical, genetic, treatment, and pathologic features of three siblings with precursor B acute lymphoblastic leukemia by the order of occurrence, suggesting a potential involvement of germline mutations in the pathogenesis of the disease. Their parents denied consanguinity as well as any familial history of syndromic diseases or neoplasms. Cases 1 and 2 have experienced a relapse after achieving remission, and case 3 has been diagnosed in recent years. Recurrent cytogenetic abnormalities shared across Cases 2 and 3 raised the hypothesis that monosomy 20 may be a susceptible marker in familial B-ALL. HLAs were fully matched for Cases 2 and 3; so, Case 3 donated stem cells to his older brother (Case 2) 3 months before his own involvement. Today, these cases are in complete remission of the disease. This study supports genetic counseling and targeted germline testing in familial ALL cases and argues for cautious consideration of related donors in such cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.